title: Regarding 'HPV vaccination for cervical cancer prevention is not cost-effective in Japan'.
authors.affiliation: Unit of Health Economics, Faculty of Pharmaceutical Science, Teikyo Heisei University, Japan E-mail : i.arakawa@thu.ac.jp.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Arakawa
authors.forename: Hideki
authors.initials: H
authors.lastname: Murasawa
authors.forename: Ryo
authors.initials: R
authors.lastname: Konno
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D007564:Japan; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D014611:Vaccination
chemical_list: D053918:Papillomavirus Vaccines